✦ LIBER ✦

Capecitabine plus paclitaxel in metastatic breast cancer

Book ID: 120856692
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 138 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414440-00028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

463 A multicenter phase II study of cape

463 A multicenter phase II study of capecitabine plus paclitaxel in metastatic breast cancer: Survival update

✍ W. Gradishar; L. Meza; T. Hill; D. Samid; Y.-M. Chen; B. Amin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Low dose capecitabine plus weekly paclit

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609

✍ Tetsuya Taguchi, Daigo Yamamoto, Norikazu Masuda… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 231 KB

Efficacy and toxicity of Trastuzumab and

Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer

✍ Onder Tonyali, Mustafa Benekli, Veli Berk… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 197 KB

Capecitabine/paclitaxel in first-line tr

Capecitabine/paclitaxel in first-line treatment of metastatic breast cancer

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Paclitaxel plus Bevacizumab versus Pacli

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

✍ Miller, Kathy; Wang, Molin; Gralow, Julie; Dickler, Maura; Cobleigh, Melody; Per 📂 Article 📅 2007 🏛 Massachusetts Medical Society 🌐 English ⚖ 287 KB

Paclitaxel plus Bevacizumab versus Pacli

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

✍ Mayer, E.L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 135 KB